Clinical and pathological characteristics of HIV- and HHV-8–negative Castleman disease-Reference-Cited by-同舟云学术

Clinical and pathological characteristics of HIV- and HHV-8–negative Castleman disease

Published:2017-03-23 Issue:12 Volume:129 Page:1658-1668
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Yu Li¹²,Tu Meifeng³,Cortes Jorge⁴,Xu-Monette Zijun Y.¹,Miranda Roberto N.¹,Zhang Jun¹,Orlowski Robert Z.⁵,Neelapu Sattva⁵,Boddu Prajwal C.⁴,Akosile Mary A.⁴,Uldrick Thomas S.⁶,Yarchoan Robert⁶,Medeiros L. Jeffrey¹,Li Yong⁷,Fajgenbaum David C.⁸,Young Ken H.¹⁹

Affiliation:

1. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX;

2. Department of Hematology, The Second Affiliate Hospital of Nanchang University, Nanchang, China;

3. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital and Institute, Peking, China;

4. Department of Leukemia and

5. Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX;

6. HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;

7. Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH;

8. Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; and

9. Graduate School of Biomedical Sciences, The University of Texas Health Science Center, Houston, TX

Abstract

Key Points HIV-negative UCD and iMCD are heterogeneous at the clinical, immunophenotypic, and pathologic levels. Complete surgical resection is the primary option of treatment of UCD, while siltuximab is more effective for iMCD than rituximab.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/129/12/1658/1399751/blood748855.pdf

Reference40 articles.

1. HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy;Fajgenbaum;Blood,2014

2. HHV-8 infection status of AIDS-unrelated and AIDS-associated multicentric Castleman’s disease;Suda;Pathol Int,2001

3. Idiopathic multicentric Castleman’s disease: a systematic literature review;Liu;Lancet Haematol,2016

4. Use of a claims database to characterize and estimate the incidence rate for Castleman disease;Munshi;Leuk Lymphoma,2015

5. Diagnosis and management of Castleman disease;Soumerai;Cancer Contr,2014

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal Neoplasms with Concurrent Castleman-Like Regional Lymphadenopathy;International Journal of Surgical Pathology;2024-08-30

2. A rare case report of hyaline-vascular type Castleman disease in the presacral region;Frontiers in Oncology;2024-08-26

3. Clinical Insights into the Lymphatic System- Functions and Disorders;International Journal of Innovative Science and Research Technology (IJISRT);2024-08-17

4. Continuous therapy in HHV-8 negative Multicentric Castleman Disease and prolonged progression-free survival;Journal of Hematology & Oncology;2024-08-06

5. Overview of Research Status in Castleman Disease;Clinical Lymphoma Myeloma and Leukemia;2024-06